is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
In light of the ongoing COVID-19 situation, and in consultation with key stakeholders across the pharma community, CPhI North America has made the difficult decision to cancel the live event in Philadelphia, originally rescheduled for September 9-11.
This conclusion was not one that was reached easily, but with the health and safety of our community in mind, we have made the proactive decision to act now, allowing our industry partners enough time to adjust their plans.
The dates for CPhI North America 2021 will be April 20 – 22nd. We look forward to welcoming all our attendees and exhibitors next April for a successful CPhI North America.
Responding to the need to connect + collaborate in today’s pharmaceutical industry, CPhI is excited to present you with the CPhI: Festival of Pharma, a new virtual extravaganza for the global pharma community.
From October 5-16, 2020, the CPhI: Festival of Pharma will combine the world’s leading pharma companies, incredible speakers and unparalleled networking opportunities, all of it under the most advanced digital ecosystem.
No matter where you are in the pharmaceutical supply chain, CPhI North America’s expo hall has you covered. It’s an expansive marketplace uniting pharma buyers and sellers, strategically positioned in seven unique zones.
Biopharma comprises 25% of the total pharma market and revenues have gone up by over 6000% from the 1990s to now. What are companies doing to keep up with this growth and innovation? Read this article to find out.
How is biopharma striking a balance between modernizing drug development & delivery and the effort to rein in R&D expenses? While change is unlikely to be quick, there is consensus that pharma does need to embrace changes in drug development and delivery fully explore the wide range of opportunities that exist.
Pipeline diversification, emerging therapies and shifting customer demands are the real dynamics reshaping the contract manufacturing market, according to experts. Almost every article written about contracting reports that demand for outsourced manufacturing services is growing and states that the CDMO sector is consolidating.